Title: “New Study Reveals Alarming Figures: 16 Million Americans Affected by Cannabis Use Disorder”
Subtitle: Experts stress the importance of early screening and treatment for patients exhibiting symptoms of the disorder.
In a review article published in the prestigious New England Journal of Medicine, recent findings shed light on the rising prevalence of cannabis use disorder in the United States. The study highlights the urgent need for doctors to screen and treat patients who display symptoms of the disorder.
The research indicates that approximately one in every five Americans, aged 12 and older, used cannabis in 2021. Even more alarming, over 16 million individuals met the criteria for cannabis use disorder as specified by the DSM-5-TR (Diagnostic and Statistical Manual for Mental Disorders, 5th Edition, Text Revision). The majority of those affected were young adults between the ages of 18 and 25, with over 14 percent meeting the diagnostic criteria.
The study aims to dispel the commonly held misconception that cannabis use is harmless, exposing the potential side effects and addictive nature of the drug. Individuals suffering from cannabis use disorder often experience difficulties in controlling their usage despite negative consequences, and exhibit cravings for the drug. Research has shown that the disorder is commonly associated with other psychiatric conditions.
The physical symptoms of cannabis use disorder can range from yellowing of the fingertips to increased feelings of depression and anxiety. Clinicians diagnose the disorder based on the presence of two or more criteria outlined in the DSM-5-TR.
To mitigate the risks associated with cannabis use disorder, the review article stresses the importance of educating physicians about its health risks. It also aims to enhance public awareness of the disorder and inform individuals about available treatment options.
Not only can excessive cannabis use lead to emergency room visits, but it also poses an increased risk of car accidents. Alarmingly, it is young adults aged 18 to 25 who have the highest rates of cannabis-related emergency department visits.
The University of Maryland School of Medicine’s (UMSOM) Kahlert Institute for Addiction Medicine is at the forefront of pioneering research and innovation in addiction medicine. The institute’s mission is to understand the neurological differences in the brain that make individuals more susceptible to drug abuse and addiction. By bringing together experts in the field, UMSOM aims to develop effective treatment strategies.
Currently, seven recognized disorders closely related to cannabis use are being investigated, with researchers aiming to gain a deeper understanding of these conditions in order to develop targeted treatments.
To address the disorder effectively, the U.S. Preventive Services Task Force recommends early screening for cannabis use disorder. Therapeutic options such as Cognitive Interactive Therapy (CBT) and Motivational Enhancement Therapy (MET) are available to help manage symptoms and reduce cannabis use. While telehealth services have improved access to therapy, stigma and a shortage of mental healthcare professionals still pose barriers to treatment.
The study’s findings serve as a wake-up call for healthcare professionals and the general public, emphasizing the urgency of early intervention and treatment programs for those affected by cannabis use disorder.
“Prone to fits of apathy. Devoted music geek. Troublemaker. Typical analyst. Alcohol practitioner. Food junkie. Passionate tv fan. Web expert.”